Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics

 LIVE Symposium

Tuesday, July 23, 2024
1:00 - 4:00 PM Eastern Time

The COVID-19 pandemic brought mRNA-based vaccines to the forefront. However, many challenges still exist in the field of RNA medicines, including identifying what additional diseases could be targeted and how best to deliver vaccines and other therapeutics.

In this virtual symposium brought to you by The Scientist, an expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.

Symposium program

1:00 PM – Introduction

1:10 PM- Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics

Kathryn Whitehead, PhD

1:45 PM – Engineering Synthetic Biodegradable Lipid Nanoparticles for mRNA Vaccines

Qiaobing Xu, PhD

2:20 PM – Next-Generation RNA Vaccines & Therapies

Anna Blakney, PhD 

2:55 PM – Enabling high dose RNA vaccination for the development of a multivalent enterovirus vaccine

Jesse Erasmus, PhD

3:20 PM - Open panel Q&A session
Nathan Ni from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Kathryn Whitehead, PhD Professor Chemical Engineering and Biomedical Engineering Carnegie Mellon University

Qiaobing Xu, PhD Professor Biomedical Engineering Tufts University

Anna Blakney, PhD Assistant Professor Tier 2 Canada Research Chair Michael Smith Laboratories and School of Biomedical Engineering University of British Columbia

Jesse Erasmus, PhD Director of Virology